Yonghe Medical Group Balance Sheet Health
Financial Health criteria checks 5/6
Yonghe Medical Group has a total shareholder equity of CN¥801.8M and total debt of CN¥132.6M, which brings its debt-to-equity ratio to 16.5%. Its total assets and total liabilities are CN¥2.1B and CN¥1.3B respectively.
Key information
16.5%
Debt to equity ratio
CN¥132.63m
Debt
Interest coverage ratio | n/a |
Cash | CN¥602.84m |
Equity | CN¥801.82m |
Total liabilities | CN¥1.28b |
Total assets | CN¥2.09b |
Recent financial health updates
Recent updates
Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Bounce 36% But Its Business Still Trails The Industry
Dec 12Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Leap 60% Yet They're Still Not Telling The Full Story
Sep 30Is Yonghe Medical Group (HKG:2279) Using Debt Sensibly?
May 24It's Down 34% But Yonghe Medical Group Co., Ltd. (HKG:2279) Could Be Riskier Than It Looks
Mar 31Are Yonghe Medical Group Co., Ltd. (HKG:2279) Investors Paying Above The Intrinsic Value?
Oct 19The Consensus EPS Estimates For Yonghe Medical Group Co., Ltd. (HKG:2279) Just Fell Dramatically
Sep 08Is Yonghe Medical Group Co., Ltd. (HKG:2279) Expensive For A Reason? A Look At Its Intrinsic Value
Aug 19Yonghe Medical Group's (HKG:2279) Soft Earnings Don't Show The Whole Picture
Mar 31Financial Position Analysis
Short Term Liabilities: 2279's short term assets (CN¥719.1M) exceed its short term liabilities (CN¥656.7M).
Long Term Liabilities: 2279's short term assets (CN¥719.1M) exceed its long term liabilities (CN¥628.3M).
Debt to Equity History and Analysis
Debt Level: 2279 has more cash than its total debt.
Reducing Debt: 2279's debt to equity ratio has increased from 10.4% to 16.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2279 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 2279 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 46.4% each year
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 00:27 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yonghe Medical Group Co., Ltd. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yichi Zhang | China International Capital Corporation Limited |
Junhao Zhang | Guosen Securities Co., Ltd. |
Liting Wang | Haitong International Research Limited |